CTCELLS
PrivateLast Round
Series B
Extension
Apr 1, 2026
Total Funding Raised
$15.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CTCELLS is a life sciences company that develops cancer diagnostics and cell-based immunotherapy solutions, including liquid biopsy platforms and NK cell-based therapeutics.
Sector
Telecommunications & Networking
Verticals
Consumer Electronics, Internet Providers, Wireless Infrastructure, E-commerce
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CTCELLS Comparables
Compare CTCELLS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Menarini Group | 71% |
CTCELLS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 1, 2026 | ||||
| Series B | Mar 22, 2022 | ||||
| Grant | Jun 22, 2021 | ||||
| Series A | Apr 21, 2021 |
Key People
Founding team and executive leadership
CTCELLS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series B |
| UTC Investment | Series A, Series B |
| KISED | Grant |
| KB Securities | Series A |
| Mirae Asset Capital | Series B |
| Enlight Ventures | Series A, Series B |
| LSK Investment | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Raised $6.63M in a Series B Extension round.
- Nov 13, 2025
Grew 43% QoQ from 7 to 10 employees.
CTCELLS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CTCELLS's valuation, stock price, and market status.
Is CTCELLS a public or private company?
CTCELLS is a private company.
What is the current stock price of CTCELLS?
CTCELLS is a private company with no public stock price. Caplight tracks CTCELLS's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CTCELLS worth (valuation)?
Valuation information for CTCELLS is not publicly available.
Can I buy CTCELLS stock?
CTCELLS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CTCELLS's last funding round?
CTCELLS's most recent funding round was Series B Extension on April 1, 2026.
Who are the main investors in CTCELLS?
Key investors in CTCELLS include InterVest, UTC Investment, KISED, KB Securities, Mirae Asset Capital.
Will CTCELLS IPO soon?
No public IPO plans have been announced for CTCELLS.
How can I track CTCELLS secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CTCELLS's secondary market activity and sign up for updates.